Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue
The clinical presentation of dengue virus (DENV) infection is variable. Severe complications mainly result from exacerbated immune responses. Type I interferons (IFN-I) are important in antiviral responses and form a crucial link between innate and adaptive immunity. Their contribution to host defense during DENV infection remains under-studied, as direct quantification of IFN-I is challenging. We combined ultra-sensitive single-molecule array (Simoa) digital ELISA with IFN-I gene expression to elucidate the role of IFN-I in a well-characterized cohort of hospitalized Cambodian children undergoing acute DENV infection. Higher concentrations of type I IFN proteins were observed in blood of DENV patients, compared to healthy donors, and correlated with viral load. Stratifying patients for disease severity, we found a decreased expression of IFN-I in patients with a more severe clinical outcome, such as dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). This was seen in parallel to a correlation between low IFNα protein concentrations and decreased platelet counts. Type I IFNs concentrations were correlated to frequencies of plasmacytoid DCs, not DENV-infected myloid DCs and correlated inversely with neutralizing anti-DENV antibody titers. Hence, type I IFN produced in the acute phase of infection is associated with less severe outcome of dengue disease..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Frontiers in Immunology - 11(2020) |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vinit Upasani [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Dengue virus |
|---|
| doi: |
10.3389/fimmu.2020.605087 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ009026002 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ009026002 | ||
| 003 | DE-627 | ||
| 005 | 20230501174346.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fimmu.2020.605087 |2 doi | |
| 035 | |a (DE-627)DOAJ009026002 | ||
| 035 | |a (DE-599)DOAJ2dcfc1a80e81473cbaa881df4b63c9c4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC581-607 | |
| 100 | 0 | |a Vinit Upasani |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The clinical presentation of dengue virus (DENV) infection is variable. Severe complications mainly result from exacerbated immune responses. Type I interferons (IFN-I) are important in antiviral responses and form a crucial link between innate and adaptive immunity. Their contribution to host defense during DENV infection remains under-studied, as direct quantification of IFN-I is challenging. We combined ultra-sensitive single-molecule array (Simoa) digital ELISA with IFN-I gene expression to elucidate the role of IFN-I in a well-characterized cohort of hospitalized Cambodian children undergoing acute DENV infection. Higher concentrations of type I IFN proteins were observed in blood of DENV patients, compared to healthy donors, and correlated with viral load. Stratifying patients for disease severity, we found a decreased expression of IFN-I in patients with a more severe clinical outcome, such as dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). This was seen in parallel to a correlation between low IFNα protein concentrations and decreased platelet counts. Type I IFNs concentrations were correlated to frequencies of plasmacytoid DCs, not DENV-infected myloid DCs and correlated inversely with neutralizing anti-DENV antibody titers. Hence, type I IFN produced in the acute phase of infection is associated with less severe outcome of dengue disease. | ||
| 650 | 4 | |a dengue virus | |
| 650 | 4 | |a plasmacytoid dendritic cell | |
| 650 | 4 | |a myloid dendritic cells | |
| 650 | 4 | |a interferon stimulated genes | |
| 650 | 4 | |a simoa immunoassay | |
| 650 | 4 | |a type I interferon | |
| 653 | 0 | |a Immunologic diseases. Allergy | |
| 700 | 0 | |a Vinit Upasani |e verfasserin |4 aut | |
| 700 | 0 | |a Carolina Scagnolari |e verfasserin |4 aut | |
| 700 | 0 | |a Federica Frasca |e verfasserin |4 aut | |
| 700 | 0 | |a Nikaïa Smith |e verfasserin |4 aut | |
| 700 | 0 | |a Vincent Bondet |e verfasserin |4 aut | |
| 700 | 0 | |a Axelle Vanderlinden |e verfasserin |4 aut | |
| 700 | 0 | |a Sokchea Lay |e verfasserin |4 aut | |
| 700 | 0 | |a Heidi Auerswald |e verfasserin |4 aut | |
| 700 | 0 | |a Sothy Heng |e verfasserin |4 aut | |
| 700 | 0 | |a Denis Laurent |e verfasserin |4 aut | |
| 700 | 0 | |a Sowath Ly |e verfasserin |4 aut | |
| 700 | 0 | |a Veasna Duong |e verfasserin |4 aut | |
| 700 | 0 | |a Guido Antonelli |e verfasserin |4 aut | |
| 700 | 0 | |a Philippe Dussart |e verfasserin |4 aut | |
| 700 | 0 | |a Darragh Duffy |e verfasserin |4 aut | |
| 700 | 0 | |a Tineke Cantaert |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Frontiers in Immunology |d Frontiers Media S.A., 2011 |g 11(2020) |w (DE-627)DOAJ000031690 |x 16643224 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2020 |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fimmu.2020.605087 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/2dcfc1a80e81473cbaa881df4b63c9c4 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.frontiersin.org/articles/10.3389/fimmu.2020.605087/full |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1664-3224 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2020 | ||